Literature DB >> 9435697

Na(+)-dependent purine nucleoside transporter from human kidney: cloning and functional characterization.

J Wang1, S F Su, M J Dresser, M E Schaner, C B Washington, K M Giacomini.   

Abstract

Many purine nucleosides and their analogs are actively transported in the kidney. Using homology cloning strategies and reverse transcriptase-polymerase chain reactions, we isolated a cDNA encoding a Na(+)-dependent nucleoside transporter, hSPNT1, from human kidney. Functional expression in Xenopus laevis oocytes identified hSPNT1 as a Na(+)-dependent nucleoside transporter that selectively transports purine nucleosides but also transports uridine. The Michaelis constant (K(m)) of uridine (80 microM) in interacting with hSPNT1 was substantially higher than that of inosine (4.5 microM). hSPNT1 (658 amino acids) is 81% identical to the previously cloned rat Na(+)-nucleoside transporter, SPNT, but differs markedly from SPNT in terms of its primary structure in the NH2 terminus. In addition, an Alu repetitive element (approximately 282 bp) is present in the 3'-untranslated region of the hSPNT1 cDNA. Northern analysis revealed that multiple transcripts of hSPNT1 are widely distributed in human tissues including human kidney. In contrast, rat SPNT transcripts are absent in kidney and highly localized to liver and intestine. The hSPNT1 gene was localized to chromosome 15. This is the first demonstration of a purine nucleoside transporter in human kidney.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9435697     DOI: 10.1152/ajprenal.1997.273.6.F1058

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  23 in total

1.  Molecular cloning of a Na+-dependent nucleoside transporter from rabbit intestine.

Authors:  K M Gerstin; M J Dresser; J Wang; K M Giacomini
Journal:  Pharm Res       Date:  2000-08       Impact factor: 4.200

Review 2.  ABC transporters and their role in nucleoside and nucleotide drug resistance.

Authors:  Yu Fukuda; John D Schuetz
Journal:  Biochem Pharmacol       Date:  2012-01-20       Impact factor: 5.858

3.  Characterization of the mechanism of zidovudine uptake by rat conditionally immortalized syncytiotrophoblast cell line TR-TBT.

Authors:  Y Sai; T Nishimura; S Shimpo; T Chishu; K Sato; N Kose; T Terasaki; C Mukai; S Kitagaki; N Miyakoshi; Y-S Kang; E Nakashima
Journal:  Pharm Res       Date:  2008-03-12       Impact factor: 4.200

4.  Substituted cysteine accessibility method analysis of human concentrative nucleoside transporter hCNT3 reveals a novel discontinuous region of functional importance within the CNT family motif (G/A)XKX3NEFVA(Y/M/F).

Authors:  Melissa D Slugoski; Amy M L Ng; Sylvia Y M Yao; Colin C Lin; Ras Mulinta; Carol E Cass; Stephen A Baldwin; James D Young
Journal:  J Biol Chem       Date:  2009-04-20       Impact factor: 5.157

5.  Molecular analysis and structure-activity relationship modeling of the substrate/inhibitor interaction site of plasma membrane monoamine transporter.

Authors:  Horace T B Ho; Yongmei Pan; Zhiyi Cui; Haichuan Duan; Peter W Swaan; Joanne Wang
Journal:  J Pharmacol Exp Ther       Date:  2011-08-04       Impact factor: 4.030

Review 6.  Pharmacogenetics and pharmacoepigenetics of gemcitabine.

Authors:  M Candelaria; E de la Cruz-Hernández; E Pérez-Cárdenas; C Trejo-Becerril; O Gutiérrez-Hernández; A Dueñas-González
Journal:  Med Oncol       Date:  2009-11-10       Impact factor: 3.064

7.  Nucleoside transport in isolated human and rhesus choroid plexus tissue slices.

Authors:  C B Washington; K M Giacomini; C M Brett
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

8.  Identification of 8-aminoadenosine derivatives as a new class of human concentrative nucleoside transporter 2 inhibitors.

Authors:  Kazuya Tatani; Masahiro Hiratochi; Yoshinori Nonaka; Masayuki Isaji; Satoshi Shuto
Journal:  ACS Med Chem Lett       Date:  2015-01-28       Impact factor: 4.345

9.  Inhibition of histone deacetylase 7 reverses concentrative nucleoside transporter 2 repression in colorectal cancer by up-regulating histone acetylation state.

Authors:  Chaonan Ye; Kun Han; Jinxiu Lei; Kui Zeng; Su Zeng; Haixing Ju; Lushan Yu
Journal:  Br J Pharmacol       Date:  2018-10-04       Impact factor: 8.739

10.  Hypoxanthine transport in human glioblastoma cells and effect on cell susceptibility to methotrexate.

Authors:  Wei Kong; Joanne Wang
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.